Additional file 1 of A first-in-human phase 1/2 study of FGF401 and combination of FGF401 with spartalizumab in patients with hepatocellular carcinoma or biomarker-selected solid tumors

Authors :: Chan, Stephen L.
Schuler, Martin
Kang, Yoon-Koo
Yen, Chia-Jui
Edeline, Julien
Choo, Su Pin
Lin, Chia-Chi
Okusaka, Takuji
Weiss, Karl-Heinz
Macarulla, Teresa
Cattan, Stéphane
Blanc, Jean-Frederic
Lee, Kyung-Hun
Maur, Michela
Pant, Shubham
Kudo, Masatoshi
Assenat, Eric
Zhu, Andrew X.
Yau, Thomas
Lim, Ho Yeong
Bruix, Jordi
Geier, Andreas
Guillén-Ponce, Carmen
Fasolo, Angelica
Finn, Richard S.
Fan, Jia
Vogel, Arndt
Qin, Shukui
Riester, Markus
Katsanou, Vasiliki
Chaudhari, Monica
Kakizume, Tomoyuki
Gu, Yi
Porta, Diana Graus
Myers, Andrea
Delord, Jean-Pierre
Publication Year :: 2022
Publisher :: figshare, 2022.
Abstract: Additional file 1.

Full Text Access

Tools